Mosunetuzumab is a type of medication known as a monoclonal antibody. It is designed to help the immune system recognize and attack cancer cells. In this trial, it is being tested for its effectiveness and safety in treating follicular lymphoma, a type of blood cancer.

Lenalidomide is a medication that helps the immune system fight cancer and can also stop the growth of cancer cells. It is used in this trial to see how well it works in combination with mosunetuzumab for treating follicular lymphoma.

Anti-CD20 Monoclonal Antibody is a type of medication that targets a specific protein found on the surface of certain cancer cells. It helps the immune system destroy these cells. In this trial, it is being compared to the combination of mosunetuzumab and lenalidomide to evaluate its effectiveness in treating follicular lymphoma.

Chemotherapy refers to a group of medications that are used to kill or stop the growth of cancer cells. In this trial, chemotherapy is being used in combination with an anti-CD20 monoclonal antibody to compare its effectiveness against the combination of mosunetuzumab and lenalidomide in treating follicular lymphoma.

Diabetes Mellitus – A chronic condition characterized by high levels of sugar in the blood. It occurs when the body cannot produce enough insulin or effectively use the insulin it produces. Over time, high blood sugar levels can lead to damage to various organs and tissues. Symptoms may include increased thirst, frequent urination, and fatigue. The disease can progress to complications affecting the heart, eyes, kidneys, and nerves. Management involves lifestyle changes and monitoring blood sugar levels.

Hypertension – A condition where the force of the blood against the artery walls is consistently too high. It often develops over many years and can lead to serious health problems if left unmanaged. Symptoms are usually not noticeable, which is why it is often called a “silent killer.” Over time, it can cause damage to the heart, blood vessels, and other organs. Risk factors include age, genetics, and lifestyle choices. Regular monitoring and lifestyle adjustments are crucial for managing this condition.

Asthma – A respiratory condition marked by spasms in the bronchi of the lungs, causing difficulty in breathing. It is usually connected to allergic reactions or other forms of hypersensitivity. Symptoms include wheezing, coughing, chest tightness, and shortness of breath. The severity of symptoms can vary and may be triggered by exercise, allergens, or respiratory infections. Asthma can be managed by avoiding triggers and using prescribed medications. Regular monitoring and a personalized action plan are essential for control.

Osteoarthritis – A degenerative joint disease characterized by the breakdown of cartilage and underlying bone. It commonly affects the knees, hips, and hands, leading to pain and stiffness. The condition progresses slowly, with symptoms worsening over time. Risk factors include age, obesity, joint injuries, and genetics. It can limit daily activities and reduce the quality of life. Management focuses on maintaining joint function and reducing pain.

Chronic Obstructive Pulmonary Disease (COPD) – A group of lung diseases that block airflow and make breathing difficult. It includes emphysema and chronic bronchitis, often caused by long-term exposure to irritating gases or particulate matter, most commonly from cigarette smoke. Symptoms include breathing difficulty, cough, mucus production, and wheezing. The disease progresses over time, leading to decreased lung function. Lifestyle changes and avoiding lung irritants are important for managing symptoms.